Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles

Assaf A. Gilad, Hanneke W M Van Laarhoven, Michael T Mcmahon, Piotr Walczak, Arend Heerschap, Michal Neeman, Peter C Van Zijl, Jeff W Bulte

Research output: Contribution to journalArticle

Abstract

A major challenge for cellular and molecular MRI is to study interactions between two different cell populations or biological processes. We studied the possibility to simultaneously image contrast agents based on two different MRI contrast mechanisms: chemical exchange saturation transfer (CEST) and enhancement of T2 relaxation. Various amounts of superparamagnetic iron oxide (SPIO) nanoparticles were mixed with a fixed concentration (250 μM) of the CEST agent poly-L-lysine. T2 maps, CEST maps, and frequency-dependent saturation spectra were then measured. Color-coded overlay maps demonstrated the feasibility of concurrent dual contrast enhancement. We found that at concentrations lower than 5 μg(Fe)/mL both contrast agents can be imaged simultaneously. At higher concentrations, the iron-based agent can be used to "shut off" the signal arising from the CEST agent. These initial findings are a first step toward using dual CEST/T2 contrast imaging for studying multiple cellular or molecular targets simultaneously in vivo. Magn Reson Med 61:970-974, 2009.

Original languageEnglish (US)
Pages (from-to)970-974
Number of pages5
JournalMagnetic Resonance in Medicine
Volume61
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Contrast Media
Biological Phenomena
Nanoparticles
Lysine
Iron
Color
Population
ferric oxide

Keywords

  • CEST agent
  • Molecular imaging
  • Superparamagnetic iron oxide

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles. / Gilad, Assaf A.; Van Laarhoven, Hanneke W M; Mcmahon, Michael T; Walczak, Piotr; Heerschap, Arend; Neeman, Michal; Van Zijl, Peter C; Bulte, Jeff W.

In: Magnetic Resonance in Medicine, Vol. 61, No. 4, 04.2009, p. 970-974.

Research output: Contribution to journalArticle

@article{18ce1c90ffc2445680aaa941047c2ba3,
title = "Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles",
abstract = "A major challenge for cellular and molecular MRI is to study interactions between two different cell populations or biological processes. We studied the possibility to simultaneously image contrast agents based on two different MRI contrast mechanisms: chemical exchange saturation transfer (CEST) and enhancement of T2 relaxation. Various amounts of superparamagnetic iron oxide (SPIO) nanoparticles were mixed with a fixed concentration (250 μM) of the CEST agent poly-L-lysine. T2 maps, CEST maps, and frequency-dependent saturation spectra were then measured. Color-coded overlay maps demonstrated the feasibility of concurrent dual contrast enhancement. We found that at concentrations lower than 5 μg(Fe)/mL both contrast agents can be imaged simultaneously. At higher concentrations, the iron-based agent can be used to {"}shut off{"} the signal arising from the CEST agent. These initial findings are a first step toward using dual CEST/T2 contrast imaging for studying multiple cellular or molecular targets simultaneously in vivo. Magn Reson Med 61:970-974, 2009.",
keywords = "CEST agent, Molecular imaging, Superparamagnetic iron oxide",
author = "Gilad, {Assaf A.} and {Van Laarhoven}, {Hanneke W M} and Mcmahon, {Michael T} and Piotr Walczak and Arend Heerschap and Michal Neeman and {Van Zijl}, {Peter C} and Bulte, {Jeff W}",
year = "2009",
month = "4",
doi = "10.1002/mrm.21928",
language = "English (US)",
volume = "61",
pages = "970--974",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles

AU - Gilad, Assaf A.

AU - Van Laarhoven, Hanneke W M

AU - Mcmahon, Michael T

AU - Walczak, Piotr

AU - Heerschap, Arend

AU - Neeman, Michal

AU - Van Zijl, Peter C

AU - Bulte, Jeff W

PY - 2009/4

Y1 - 2009/4

N2 - A major challenge for cellular and molecular MRI is to study interactions between two different cell populations or biological processes. We studied the possibility to simultaneously image contrast agents based on two different MRI contrast mechanisms: chemical exchange saturation transfer (CEST) and enhancement of T2 relaxation. Various amounts of superparamagnetic iron oxide (SPIO) nanoparticles were mixed with a fixed concentration (250 μM) of the CEST agent poly-L-lysine. T2 maps, CEST maps, and frequency-dependent saturation spectra were then measured. Color-coded overlay maps demonstrated the feasibility of concurrent dual contrast enhancement. We found that at concentrations lower than 5 μg(Fe)/mL both contrast agents can be imaged simultaneously. At higher concentrations, the iron-based agent can be used to "shut off" the signal arising from the CEST agent. These initial findings are a first step toward using dual CEST/T2 contrast imaging for studying multiple cellular or molecular targets simultaneously in vivo. Magn Reson Med 61:970-974, 2009.

AB - A major challenge for cellular and molecular MRI is to study interactions between two different cell populations or biological processes. We studied the possibility to simultaneously image contrast agents based on two different MRI contrast mechanisms: chemical exchange saturation transfer (CEST) and enhancement of T2 relaxation. Various amounts of superparamagnetic iron oxide (SPIO) nanoparticles were mixed with a fixed concentration (250 μM) of the CEST agent poly-L-lysine. T2 maps, CEST maps, and frequency-dependent saturation spectra were then measured. Color-coded overlay maps demonstrated the feasibility of concurrent dual contrast enhancement. We found that at concentrations lower than 5 μg(Fe)/mL both contrast agents can be imaged simultaneously. At higher concentrations, the iron-based agent can be used to "shut off" the signal arising from the CEST agent. These initial findings are a first step toward using dual CEST/T2 contrast imaging for studying multiple cellular or molecular targets simultaneously in vivo. Magn Reson Med 61:970-974, 2009.

KW - CEST agent

KW - Molecular imaging

KW - Superparamagnetic iron oxide

UR - http://www.scopus.com/inward/record.url?scp=66249104627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66249104627&partnerID=8YFLogxK

U2 - 10.1002/mrm.21928

DO - 10.1002/mrm.21928

M3 - Article

VL - 61

SP - 970

EP - 974

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 4

ER -